Literature DB >> 20212272

Pharmacologically induced thoracic and abdominal aortic aneurysms in mice.

Yasuhisa Kanematsu1, Miyuki Kanematsu, Chie Kurihara, Tsung-Ling Tsou, Yoshitsugu Nuki, Elena I Liang, Hiroshi Makino, Tomoki Hashimoto.   

Abstract

Aortic aneurysms are common among the elderly population. A large majority of aortic aneurysms are located at two distinct aneurysm-prone regions, the abdominal aorta and thoracic aorta involving the ascending aorta. In this study, we combined two factors that are associated with human aortic aneurysms, hypertension and degeneration of elastic lamina, to induce an aortic aneurysm in mice. Roles of hemodynamic conditions in the formation of aortic aneurysms were assessed using two different methods for inducing hypertension and antihypertensive agents. In 9-week-old C57BL/6J male mice, hypertension was induced by angiotensin II or deoxycorticosterone acetate-salt hypertension; degeneration of elastic lamina was induced by infusion of beta-aminopropionitrile, a lysyl oxidase inhibitor. Irrespective of the methods for inducing hypertension, mice developed thoracic and abdominal aortic aneurysms (38% to 50% and 30 to 49%, respectively). Aneurysms were found at the two aneurysm-prone regions with site-specific morphological and histological characteristics. Treatment with an antihypertensive agent, amlodipine, normalized blood pressure and dramatically reduced aneurysm formation in the mice that received angiotensin II and beta-aminopropionitrile. However, treatment with captopril, an angiotensin-converting enzyme inhibitor, did not affect blood pressure or the incidence of aortic aneurysms in the mice that received deoxycorticosterone acetate-salt and beta-aminopropionitrile. In summary, we have shown that a combination of hypertension and pharmacologically induced degeneration of elastic laminas can induce both thoracic and abdominal aortic aneurysms with site-specific characteristics. The aneurysm formation in this model depended on hypertension but not on direct effects of angiotensin II to the vascular wall.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20212272      PMCID: PMC2859958          DOI: 10.1161/HYPERTENSIONAHA.109.140558

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  32 in total

Review 1.  Thoracic and abdominal aortic aneurysms.

Authors:  Eric M Isselbacher
Journal:  Circulation       Date:  2005-02-15       Impact factor: 29.690

2.  Histologic changes in the normal aging aorta: implications for dissecting aortic aneurysm.

Authors:  T J Schlatmann; A E Becker
Journal:  Am J Cardiol       Date:  1977-01       Impact factor: 2.778

3.  Connective tissue ageing: the influence of a lathyrogen (beta-aminopropionitrile) on the life span of female C57BL/Icrfat mice.

Authors:  I Davies; J D Schofield
Journal:  Exp Gerontol       Date:  1980       Impact factor: 4.032

4.  Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor -/- mice.

Authors:  A Daugherty; L Cassis
Journal:  Ann N Y Acad Sci       Date:  1999-11-18       Impact factor: 5.691

5.  Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response.

Authors:  A E Koch; G K Haines; R J Rizzo; J A Radosevich; R M Pope; P G Robinson; W H Pearce
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

6.  Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm.

Authors:  Gary G Deng; Baby Martin-McNulty; Drew A Sukovich; Ana Freay; Meredith Halks-Miller; Therese Thinnes; David J Loskutoff; Peter Carmeliet; William P Dole; Yi-Xin Wang
Journal:  Circ Res       Date:  2003-02-13       Impact factor: 17.367

7.  The natural history of thoracic aortic aneurysms.

Authors:  O E Dapunt; J D Galla; A M Sadeghi; S L Lansman; C K Mezrow; R A de Asla; C Quintana; S Wallenstein; A M Ergin; R B Griepp
Journal:  J Thorac Cardiovasc Surg       Date:  1994-05       Impact factor: 5.209

8.  Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice.

Authors:  Kiran Saraff; Fjoralba Babamusta; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-10       Impact factor: 8.311

9.  Angiotensin II increases monocyte binding to endothelial cells.

Authors:  J A Kim; J A Berliner; J L Nadler
Journal:  Biochem Biophys Res Commun       Date:  1996-09-24       Impact factor: 3.575

10.  A murine model of thoracic aortic aneurysms.

Authors:  John S Ikonomidis; William C Gibson; Jonathan Gardner; Sarah Sweterlitsch; Robert P Thompson; Rupak Mukherjee; Francis G Spinale
Journal:  J Surg Res       Date:  2003-11       Impact factor: 2.192

View more
  61 in total

Review 1.  Biomechanical phenotyping of central arteries in health and disease: advantages of and methods for murine models.

Authors:  J Ferruzzi; M R Bersi; J D Humphrey
Journal:  Ann Biomed Eng       Date:  2013-04-03       Impact factor: 3.934

2.  Effects of prolonged vaginal distension and β-aminopropionitrile on urinary continence and urethral structure.

Authors:  Guifang Wang; Guiting Lin; Haiyang Zhang; Xuefeng Qiu; Hongxiu Ning; Lia Banie; Thomas Fandel; Maarten Albersen; Tom F Lue; Ching-Shwun Lin
Journal:  Urology       Date:  2011-10       Impact factor: 2.649

3.  Transforming Growth Factor-β1 Inhibits Pseudoaneurysm Formation After Aortic Patch Angioplasty.

Authors:  Hualong Bai; Jung Seok Lee; Haidi Hu; Tun Wang; Toshihiko Isaji; Shirley Liu; Jianming Guo; Haiyang Liu; Katharine Wolf; Shun Ono; Xiangjiang Guo; Bogdan Yatsula; Ying Xing; Tarek M Fahmy; Alan Dardik
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-16       Impact factor: 8.311

4.  Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile-Induced Abdominal Aortic Aneurysm.

Authors:  Tatsuo Kawai; Takehiko Takayanagi; Steven J Forrester; Kyle J Preston; Takashi Obama; Toshiyuki Tsuji; Tomonori Kobayashi; Michael J Boyer; Hannah A Cooper; Hang Fai Kwok; Tomoki Hashimoto; Rosario Scalia; Victor Rizzo; Satoru Eguchi
Journal:  Hypertension       Date:  2017-09-25       Impact factor: 10.190

5.  A novel chronic advanced stage abdominal aortic aneurysm murine model.

Authors:  Guanyi Lu; Gang Su; John P Davis; Basil Schaheen; Emily Downs; R Jack Roy; Gorav Ailawadi; Gilbert R Upchurch
Journal:  J Vasc Surg       Date:  2017-03-06       Impact factor: 4.268

Review 6.  Aortic Aneurysms.

Authors:  Hong Lu; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06       Impact factor: 8.311

7.  Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase.

Authors:  Takehiko Takayanagi; Kevin J Crawford; Tomonori Kobayashi; Takashi Obama; Toshiyuki Tsuji; Katherine J Elliott; Tomoki Hashimoto; Victor Rizzo; Satoru Eguchi
Journal:  Clin Sci (Lond)       Date:  2014-06       Impact factor: 6.124

8.  Translational research using a mouse model of intracranial aneurysm.

Authors:  Kosuke Wada; Hiroshi Makino; Kenji Shimada; Fumiaki Shikata; Atsushi Kuwabara; Tomoki Hashimoto
Journal:  Transl Stroke Res       Date:  2013-11-06       Impact factor: 6.829

9.  The role of lysyl oxidase family members in the stabilization of abdominal aortic aneurysms.

Authors:  Ebony Washington Remus; Robert E O'Donnell; Kathryn Rafferty; Daiana Weiss; Giji Joseph; Katalin Csiszar; Sheri F T Fong; W Robert Taylor
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-17       Impact factor: 4.733

10.  Increased 18F-FDG uptake is predictive of rupture in a novel rat abdominal aortic aneurysm rupture model.

Authors:  Sean J English; Morand R Piert; Jose A Diaz; David Gordon; Abhijit Ghosh; Louis G DʼAlecy; Steven E Whitesall; Ashish K Sharma; Elise P DeRoo; Tessa Watt; Gang Su; Peter K Henke; Jonathan L Eliason; Gorav Ailawadi; Gilbert R Upchurch
Journal:  Ann Surg       Date:  2015-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.